The National Cancer Institute (NCI) has launched a natural history study of COVID-19 in cancer patients. Blood tests, medical history and imaging will be obtained from 2,000 cancer patients, who are more susceptible to serious illness if they contract COVID-19. Anticipated outcomes of the trial include understanding genetic risk factors of COVID-19 diagnoses while patients are undergoing cancer treatment, as well as establish a repository of blood tests and imaging results for future research.
To learn more about this study, click
here.
No comments:
Post a Comment